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PM10An approach for assessing the inhalation bioaccessibility of Pb in the PM10 size fraction is presented, using an in vitro
simulated epithelial lung ﬂuid to represent the extracellular environment of the lung. The developed inhalation bio-
accessibility method (IBM) is applied to a range of urban surface soils and mining wastes obtained fromMitrovica,
Kosovo, a site where impacts upon human health following exposure to Pb have been internationally publicised. All
Pb determinations were undertaken by inductively coupled plasmamass spectrometry (ICP-MS). The pseudo-total
concentration of Pb (microwave acid digestion using aqua-regia) varied between matrices: smelter (20,900–
72,800 mg kg−1), topsoil (274–13,700 mg kg−1), and tailings (2990 mg kg−1–25,300 mg kg−1). The in vitro
inhalation bioaccessibility was typically several orders of magnitude lower: smelter (7.0–965 mg kg−1), topsoil
(9.8–1060 mg kg−1), and tailings (0.7 mg kg−1–49.2 mg kg−1). The % inhalation bioaccessibility ranged from
0.02 to 11.0%, with the higher inhalation bioaccessible Pb concentrations being observed for samples from the
Bosniak Mahalla area of Mitrovica (an area proposed for the relocation of internally displaced peoples). The
estimated inhalation dose (for adults) calculated from the PM10 pseudo-total Pb concentration ranged from 0.369
to 1.284 μg kg−1BW day−1 (smelter), 0.005–0.242 μg kg−1BW day−1 (topsoil), and 0.053–0.446 μg kg−1BW day−1
(tailings).Whendaily inhalation doseswere calculated using the bioaccessible Pb concentration themodelled expo-
sure dosesweremuch lower: smelter (0.0001–0.0170 μg kg−1BW day−1), topsoil (0.0002–0.0187 μg kg−1BW day−1)
and tailings (0.0001–0.0009 μg kg−1BW day−1). Modelled for the neutral pH conditions of the interstitial
lung environment, the results indicate a low potential inhalation bioaccessibility for Pb in these samples. Given
the already elevated environmental Pb burden experienced by the local population, where signiﬁcant prolonged
dust or particulate generating activities are taking place, or where the inhaled particles are phagocytized, then
inhalation exposure has the potential to signiﬁcantly add to the overall Pb burden. Such data are important for
local policy makers to better enable them to assess risk, especially in areas where soils/dusts have elevated levels
of contamination.
© 2014 Elsevier Ltd. All rights reserved.1. Introduction
Potentially harmful elements (PHEs) released into the environment
either through natural or anthropogenic activities may cause adverse
health effects to humans. The threemain exposure pathways to humans
are via ingestion, inhalation and topical absorption (typically referred to
as dermal as usually across the skin) (Environment Agency, 2009a). For
public health safety it is essential that acceptable methods are devel-
oped for estimating realistic human exposure concentrations resulting
from exposure to PHEs in the environment. Several protocols have
been developed for the ingestion pathway including physiologically-. Entwistle).based in vitro bioaccessibility methods. Previous bioaccessibility work
has predominantly focused on As, Cd and Pb where the ingestion path-
way is considered to be the main exposure route to humans. Indeed
there are several in vitro oral models currently in use for contaminants
in food and environmental matrices, and reviews of this work are nu-
merous (e.g. Abrahams, 2012; Hur et al., 2009; Intawongse and Dean,
2006; Oomen et al., 2002; Ruby et al., 1999; Wragg and Cave, 2003).
In certain contexts and for certain elements however, inhalation, and
speciﬁcally the inhalation of suspended particles in air, can pose an
increased human health risk via this exposure pathway (Colombo
et al., 2008; Harrad et al., 2004; Jones-Otazo et al., 2005; Voutsa and
Samara, 2002). Indeed for Ni, the inhalation pathway is considered to
be the most signiﬁcant exposure pathway (Environment Agency,
2009b). Epidemiological, animal toxicological and in vitro studies have
indicated that it is the chemical composition, as well as the physical
presence, of the inhaled particles that plays a major role in associated
Table 1
The composition and concentrations of in vitro lung bioaccessibility ﬂuids.
Composition Original Gamble
solution
Pseudo
alveolar ﬂuid
Simulated
lung ﬂuid
Artiﬁcial
interstitial ﬂuid
Gamble
solution
Modiﬁed Gamble
solution
Synthetic
serum
Gamble
solution
SELF
MgCl2⋅6H2O (mg L−1) 203 212 212 203 200
NH4Cl (mg L−1) 535 5300 535 118
NaCl (mg L−1) 6019 6415 6400 6193 6786 6800 6786 6400 6020
CaCl2 (mg L−1) 22 22
CaCl2⋅2H2O (mg L−1) 368 255 255 368 290 225 256
Na2SO4 (mg L−1) 71 79 71 72
H2SO4 (mg L−1) 45 510 45
Na2SO4⋅10H2O (mg L−1) 179
Na2HPO4 (mg L−1) 148 148 142 150 150
NaH2PO4 (mg L−1) 142 144 144
NaH2PO4⋅H2O (mg L−1) 1700
H3PO4 ( mg L−1) 1200
NaHCO3 (mg L−1) 2604 2703 2700 2604 2268 2300 2268 2700 2700
Na2CO3 ( mg L−1) 630
NaHC4H4O6⋅2H2O (sodium hydrogen tartrate dihydrate) (mg L−1) 180 180
H2C6H5O7Na⋅2H2O (sodium dihydrogen citrate dihydrate) (mg L−1) 97 153 153
CH3CHOHCOONa (sodium citrate) (mg L−1) 175 52 52 160
Citric acid⋅H2O (mg L−1) 420
NaOCOCOCH3 (sodium pyruvate) (mg L−1) 0.72 172
NH2CH2COOH (glycine) (Gly) (mg L−1) 118 118 375 450 450 190 376
L-Cysteine (C3H7NO2S) (mg L−1) 121 122
DPPC (dipalmitoyl phosphatidyl choline) (C40H80NO8P) (mg L−1) 200 100
CH3COONa⋅3H2O (sodium acetate trihydrate) (mg L−1) 953 952
Sodium acetate (CH3COONa) (mg L−1) 580
HOC (COONa) (CH2COONa)2⋅2H2O (sodium citrate dihydrate) (mg L−1) 97 590
C3H5NaO3 (sodium lactate) (mg L−1) 290
KCl (mg L−1) 298 298 298
Potassium hydrogen phthalate (C8H5KO4) (mg L−1) 200
C14H23N3O10 (DTPA) (pentetic acid) (mg L−1) 79
C21H38NCl (ABDAC) ( mg L−1) (benzalkonium chloride) 50
Ascorbic acid (mg L−1) 18
Uric acid (mg L−1) 16
Glutathione (mg L−1) 30
Albumin (mg L−1) 260
Mucin (mg L−1) 500
pH (adjustment with HCl) 7.6 7.4 7.3 7.4 7.3 7.4
Reference Moss, 1979 Takaya et al.,
2006,
Taunton
et al., 2010
Stopford et al.,
2003
Wragg and
Klinck, 2007
Gray et al.,
2010;
Kanapilly
et al., 1973
Caboche
et al., 2011
This study
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Table 2
Simulated epithelial lung ﬂuid formulation.
Reagent Weight of reagent (mg) made up to 500 mL
(A) Inorganic phase reagent
NaCl 6020
CaCl2 256
Na2HPO4 150
NaHCO3 2700
KCl 298
MgCl2 200
Na2SO4 72
(B) Organic phase reagent
Ascorbic acid 18
Uric acid 16
Glutathione 30
(C) Additional reagents
Albumin 260
Cysteine 122
DPPC 100
Glycine 376
Mucin 500
134 N. Boisa et al. / Environment International 70 (2014) 132–142toxic, carcinogenic and other health effects (e.g. Adamson et al., 2000;
Ghio and Devlin, 2001; Godleski et al., 2002; Hunt et al., 2003).
With respect to the inhalation route, a particle may reside in one of
at least two “compartments”: the extracellular environment typiﬁed
by lung ﬂuid of neutral pH and the more acidic environment within
macrophages (Zoitos et al., 1997). The pioneer synthetic lung ﬂuid
(SLF), commonly referred to as Gamble's solution, has been widely
used for the exposure assessment of humans to inhalable pollutants.
Gamble's solution attempts to simulate the extracellular environment
of the deep lung (Holliday, 2000; Margues et al., 2011). This initial for-
mula has been modiﬁed by several researchers (Caboche et al., 2011;
Wragg and Klinck, 2007) but the name “Gamble solution” is often
retained. Names like “modiﬁed Gamble's solution” (Gray et al., 2010),
“Gamble serum simulant” (Ansoborlo et al., 1990), “simulated lung
ﬂuid” (Taunton et al., 2010), “synthetic serum” (Kanapilly et al., 1973),
“artiﬁcial interstitial ﬂuid” (Stebounova et al., 2011; Stopford et al.,
2003), and “pseudo alveolar ﬂuid” (Takaya et al., 2006) have also been
employed. The formulae for these different versions of Gamble's
solution are summarised in Table 1 and indicate both similarities and
differences in their constituent compounds. Several other substitute
ﬂuids such as deionised water, dilute acids, polydentate chelants
(i.e. ethylene diaminetetraacetic acid), acetate buffers, phosphate
buffers and physiological sodium chloride solutions have also been
used to estimate inhalation bioaccessibility (e.g. Artelt et al., 1998;
Birmili et al., 2006; Canepari et al., 2006, 2010; Harrington et al., 2012;
Santos et al., 2009), as have ﬂuids that represent different conditions
within the lung, such as artiﬁcial lysosomal ﬂuid representative of the
more acidic ﬂuid with which particles come into contact after phagocy-
tosis (Colombo et al., 2008). Whilst the Bioaccessibility Research Group
of Europe (BARGE) has formulated ﬂuids for the different compart-
ments of the digestive system (mouth, stomach and intestine) that
attempt to mimic a full complement of chemical groups identiﬁed in
the digestive ﬂuids of healthy humans i.e. the Uniﬁed Bioaccessibility
Method (UBM) (Wragg et al., 2009), there is presently no consensus
on the ﬂuid composition for the inhalation pathway and many existing
ﬂuids appear to be limited when their formulae at the molecular level
are compared with the UBM for oral bioaccessibility studies. At the
molecular level the UBM contains minerals (salts), water, proteins
(e.g. albumin,mucin, uric acid) and lipids (bile salt); thus all fourmolec-
ular components of human body ﬂuids are represented. Typical recipes
(Table 1) for SLFs indicate sufﬁcient salt (mineral) content but appear to
be deﬁcient in representing the mix of organic molecules in the native
respiratory tract environment (Margues et al., 2011). Though some au-
thors have substituted proteins with citrates/citric acid and organic
acids with acetates (Gray et al., 2010; Stopford et al., 2003; Takaya
et al., 2006; Wragg and Klinck, 2007), it may be difﬁcult to justify
these substitutions especially when the same organic molecules have
been used in other aqueous in vitro protocols (e.g. UBM) and are readily
available on the market. Lipids, known to be present in SLFs (Hamm
et al., 1996; Kendall, 2007; Lohninger et al., 1983), have also been
excluded in many lung bioaccessibility models with minimal to no
justiﬁcation in the literature.
The primary aims of this study were the development of i) a robust
in vitro simulated epithelial lung ﬂuid (SELF), to represent the extracel-
lular environment of the lung, and ii) an inhalation bioaccessibility
extraction (IBM) protocol. The protocol was then used, iii) to assess
the inhalation bioaccessibility of Pb in the PM10 size fraction that origi-
nate from surface soils, tailings and smelter wastes from across
Mitrovica, Kosovo. A mounting body of literature underlines the grow-
ing concern for the impact of PM, especially the bPM10 fraction on
human health. The inhalation of dust derived from soils is generally an
underestimated exposure to date. Mass contributions to ambient PM10
in several cities of the world have been traced to several sources includ-
ing soil materials (Almeida et al., 2005; Bi et al., 2007; Lim et al., 2010;
Marcazzan et al., 2003). Signiﬁcant human health risks at Mitrovica
have been identiﬁed originating from the inhalation of ambient dustaerosols containing PHEs (UNEP, 2010). Ardtisoglou and Samara
(2005) in their investigation of total suspended particulate matter and
associated trace elements in Mitrovica identiﬁed the resuspension of
soil dust as themost signiﬁcant contributor of PHEs into the local atmo-
sphere. Our focus was on the PM10 fraction. Following inhalation, parti-
cles with aerodynamic diameters of N10 μmaremainly deposited in the
upper respiratory tract, whilst particles with aerodynamic diameters of
less than or equal to 10 μm are likely (N50%) to reach the tracheobron-
chial region (Merget and Rosner, 2001). The larger inhaled particles are
known to become trapped in the mucus that lines the airways and are
transported by cilia away from the lungs (the so calledmucociliary esca-
lator) and subsequently expectorated or swallowed (gastro-intestinal
pathway). Particles b4 μm are mainly respirable (i.e. deposit in the
alveolar region or deep lung).2. Experimental
2.1. Simulated epithelial lung ﬂuid (SELF) formulation
A critical review of the published literature indicates that inorganic
salts, surfactant lipids, large molecular-mass proteins, low molecular-
mass antioxidant proteins and organic acids are all native to the
epithelial lung ﬂuids of healthy non-smoking humans (Cantin et al.,
1990; Hamm et al., 1996; Kendall, 2007; Kirkham and Rahman, 2006;
Lohninger et al., 1983; Vanbever et al., 1999; Vliet et al., 1999). General-
ly the range of inorganic salts (sodium chloride, calcium chloride, sodi-
um dihydrogen phosphate, sodium bicarbonate, potassium chloride,
magnesium chloride hexahydrate, sodium sulphate) and their concen-
trations used in existing models (Table 1) closely approximate
published in vivo data for healthy humans (Cadwell et al., 2002; Hull
et al., 1998; Jayaraman et al., 2001; Joris et al., 1993; Knowles et al.,
1997; Vanthanouvong and Roomans, 2004; Zhang and Engelhardt,
1999). For our SELF formulation the same salts and similar concentra-
tionsweremaintained (Table 2A). The in vivo concentrations of ascorbic
acid, uric acid and glutathione in the respiratory tract ﬂuids of healthy
human subjects have been documented as 17.6 mg L−1, 15.1 mg L−1,
30.7 mg L−1, respectively (Cross et al., 1994), and approximately
the same concentrations were chosen for this formulation (Table 2B).
Similarly, dipalmitoyl phosphatidyl choline (DPPC), a major lipid in
human respiratory tract ﬂuids (Gregory et al., 1991; Griese, 1999;
Johansson et al., 1994; Pison et al., 1986), is included. A concentration
of 100 mg L−1 DPPC is suitable for mimicking the airway's ﬂuid surfac-
tant properties (Davies and Feddah, 2003) and was adopted as part of
the SELF formulation (Table 2C).
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tiﬁed albumin andmucin as themost abundant proteins (Bakker, 1988;
Bredberg et al., 2012; Su et al., 1998). The airwaymucus gel protects the
respiratory tract against environmental challenges (Cooper et al., 1985;
Khanvilkar et al., 2001; Thornton et al., 2008) and it has been suggested
that glycoproteins such as albumin and mucin bind with metals in
solution (Cross et al., 2001; Duranti et al., 2001) thereby inﬂuencing
metal solubility. Twining et al. (2005) adopted an albumin concentra-
tion of 200 mg L−1 in their inhalation bioaccessibility model. This
reﬂects the lower end of the reported in vivo concentration range of
50–5500 mg L−1 (Fick et al., 1984; Lamer et al., 1993). For our SELF
formulation an albumin concentration of 260 mg L−1 was adopted
(Table 2C); beyond this concentration albuminmay bind to polystyrene
and glass surfaces (Bakker, 1988; Su et al., 1998). Mucin also exhibits
extensive aggregations and forms gel-like solids at physiologic concen-
trations of 20,000–50,000mg L−1 (Bansil and Turner, 2006; Bansil et al.,
1995; Bromberg and Barr, 2000; Cao et al., 1999; Lee et al., 2005).
However, at dilute concentrations of b1500 mg L−1 such aggregations
are limited but the characteristic lubricating properties of mucin are
retained (Lee et al., 2005). A concentration of 500 mg L−1 mucin
(0.5 wt.%), sufﬁcient for the attainment of surface active properties
(Grifﬁths et al., 2010), was adopted in our SELF (Table 2C).
The interaction of metal ions with proteins is well known and can
lead to aggregation and precipitation reactions (Hughes and Klotz,
1956). Glycoproteins, such as mucin for example included in our SELF,
have been shown to interact with Pb2+ at neutral pH values reducing
the solubility of Pb (Duranti et al., 2001). However the role of proteins
and antioxidant reagents warrants further investigation as Harris and
Silberman (1988) compared the leaching efﬁciency of normal canine
serum with that of a synthetic serum and concluded the opposite that
the lower leaching efﬁciency of their synthetic serumwas due to the ab-
sence of proteins in the synthetic serum. Voutsa and Samara (2002) also
attributed the very low inhalation bioaccessibility (b1%) for Pb from
urban and industrial airborne particulate matter in their synthetic
serum to the neutral pH and/or the absence of strong Pb complexing
agents.
Organic acid components of human SLFs have previously been
represented by glycine (Ansoborlo et al., 1990; Caboche et al., 2011;
Drysdale et al., 2012; Gray et al., 2010; Kanapilly et al., 1973; Takaya
et al., 2006; Wragg and Klinck, 2007) and cysteine (Ansoborlo et al.,
1990; Harris and Silberman, 1983; Vousta and Samara, 2002; Wragg
and Klinck, 2007). Both acids help maintain the glutathione balance
(Kelly, 1999) and exhibit anti-inﬂammatory effects during endothelial
inﬂammation (Hasegawa et al., 2012). In the SELF formulation the
concentrations of glycine and cysteine were set at 376 mg L−1 and
122 mg L−1, respectively (Table 2C), and are based on the formulation
by Wragg and Klinck (2007).
2.2. Reagents
Chemicals used in ﬂuid formulation and analyses were of certiﬁed
analytical grade. Concentrated nitric acid (HNO3) and concentrated hy-
drochloric acid (HCl) were supplied by Fisher Scientiﬁc Ltd. (Loughbor-
ough, Leicestershire, UK). Sodium hydrogen phosphate (NaH2PO4) and
potassium hydrogen phosphate (NaHPO4) were purchased from
Sigma Aldrich Ltd. (Gillingham, Dorset, UK). Sodium chloride (NaCl),
anhydrous sodium sulphate (Na2SO4), potassium chloride (KCl), calci-
um chloride (CaCl2⋅2H2O), sodium bicarbonate (NaHCO3), magnesium
chloride (MgCl2⋅6H2O), sodium hydroxide (NaOH), uric acid, bovine
serum albumin (BSA) and concentrated nitric acid (69% HNO3) were
all obtained from Merck Ltd. (Poole, UK). Mucin (pig) was obtained
from Carl Roth Ltd., Germany. Ascorbic acid, glutathione, cysteine,
dipalmitoyl phosphatidyl choline (DPPC), and glycine were obtained
from Sigma Aldrich Ltd. (Gillingham, Dorset, UK). A Pb standard and
internal standard solutions (indium and terbium) were obtained
from SPEXCertPrep (Middlesex, UK). Ultra-pure water of conductivity18.2 MΩ-cm was produced by a direct QTM Millipore system
(Molsheim, France). Certiﬁed reference materials: BCR 038 (ﬂy ash
from pulverised coal with a particle size fraction of b10 μm), BCR
143R (sewage sludge amended soil with a particle size fraction of
b90 μm), BCR 176R (ﬂy ash with a particle size fraction of b105 μm),
BCR 723 (road dust with a particle size fraction of b105 μm) as well as
SRM 2783 (air particulate on ﬁlter media) were obtained from
LGC-Promochem (London, UK); a Guidance Material 102 (naturally
contaminated soil, from North Lincolnshire, with a particle size of
b40 μm) was obtained from the British Geological Survey (Keyworth,
UK).
2.3. Preparation of simulated epithelial lung ﬂuid (SELF)
The list of the chemicals required to prepare 1000 mL of SELF are
given in Table 2. To prepare 500mL of the inorganic and organic phases,
the chemicals speciﬁed in Tables 2A and 2B were dissolved in deionised
water in separate 1 L high density polyethylene (HDPE) screw top
bottles and made up to 500 mL. The 500 mL inorganic and the 500 mL
organic phases were then combined to form 1000 mL of reagent in a 1 L
bottle which contained the solids listed in Table 2C and the resulting
ﬂuid was mixed thoroughly. About 0.4 mL of HCl was added to attain
the desired pH of 7.4 ± 0.2.
2.4. Procedure for inhalation bioaccessibility extraction
A static dissolution technique was chosen. Such techniques are
amongst the easiest and most widely implemented in vitro protocols
and avoid the production of large quantities of SLF associated with
ﬂow-through systems (e.g. Zoiltos et al., 1997). An in-house test soil
was utilised for method development work. This soil sample was col-
lected froma former industrial site known for its Pbworks (St. Antony's,
Newcastle upon Tyne, UK); the soil sample was sieved with a nylon
sieve of particle size fraction 250 μm and then ball milled to reduce
the particle size to a ﬁne powder.
A respiratory tract ﬂuid volume of 0.3 mL kg−1 body mass has been
recorded for healthy non-smoking human subjects by both Miserocchi
(1997) and Noppen et al. (2000). For a 70 kg adult this would corre-
spond to 21 mL. For this study the value was rounded down to 20 mL
and set as the experimental volume of the simulated epithelial lung
ﬂuid. A similar volume has also been used in previous related studies
(Gray et al., 2010; Twining et al., 2005; Wragg and Klinck, 2007).
The basal human body temperature (37 °C) was chosen for the ex-
perimental protocol for this study. Based on McShane et al. (2003),
where a pH of 7.1 ± 0.1 was reported, and an upper pH value of 7.5 re-
ported by Fischer and Widdecombe (2006), the pH for this inhalation
bioaccessibility study was set at 7.4 ± 0.2.
In terms of a suitable sample mass a range of 250–550 mg has been
applied across a range of published studies (e.g. Drysdale et al., 2012;
Wragg and Klinck, 2007). A conservative upper annual inhalation dose
of 300 mg (PM10) was calculated as a reasonable upper-bound value
and is consistent with the published range. This was calculated for
adults according to Sexton et al. (1995) as follows:
AnnualPM10 inhalation ¼ PMlimit  V resp  EF ð1Þ
where PMlimit is the exposure limit of PM10 (40 μg/m3; this represents
the upper daily PM10 concentration not to be exceeded in a calendar
year, European Environment Agency, 2011), Vresp is the inhalation rate
(20 m3 day−1) (U.S. EPA, 1991) and EF is the exposure frequency
(365 days).
The SELF was heated to 37 ± 2 °C in a thermostatically controlled
water bath before use. Approximately 0.3 g of test samplewas accurate-
ly weighed into a centrifuge tube to which 20 mL of the prepared SELF
was added. The resulting suspensions were rotated for a range of ﬁxed
times at a speed of 30 RPM, then centrifuged at 3000 RPM for 10 min
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stored in the fridge (4 °C) for subsequent analysis. The resultant residu-
al fraction was microwave acid digested (temperature, 160 °C; power,
750 watts; extraction time, 40 min; and cooling time, 30 min) using
aqua-regia (HCl:HNO3 in the ratio 3:1 v/v) to allow both a total and a
mass balance for the system to be established. Analysis was performed
by inductively coupled plasma mass spectrometry (ICP-MS) X Series II
from Thermo Electron Corporation (Winsford, UK).
The percentage inhalation bioaccessible fraction (%IBAF) was calcu-
lated as follows:
%IBAF ¼ Cibio=Ctotal  100ð Þ ð2Þ
where Cibio is the inhalation bioaccessible concentration of Pb and Ctotal
is the total concentration of Pb determined by aqua regia digestion. For
each digestion, reagent blanks were also prepared. The ﬁltrate obtained
from the digestion was refrigerated (b4 °C) prior to analysis.
2.5. Quality control procedures
Procedural blanks were included within the inhalation bioaccessibi-
lity extraction procedure and to determine reproducibility all samples
were extracted in triplicate. For the microwave acid digestion 0.5 g of
a certiﬁed reference material (BCR 143R) was accurately weighed and
digested to assess the efﬁciency of the digestion procedure. For the
ICP-MS analysis a blank solution and two quality control standards
(low and high)were analysed after nomore than 10 unknown samples.
Instrumental detection limit for Pb was 0.1 μg L−1, with the methodFig. 1. Sample locations in Mitrovica,detection limit two orders of magnitude greater at approximately
10 μg L−1.
All reported data are based on the average of three replicate. Also to
assess the quality of data generated by the ICP-MS standard solutions (0,
20, 40, 60, 80, 100, 200, and 400 ngmL−1) were prepared and analysed
prior to the test samples.
3. Study site
Mitrovica, Northern Kosovo contains a number of former and cur-
rent metallurgical industries including the now inactive Zvecan Pb/Zn
smelter, located approximately 5 km to the north of the city (Fig. 1). In-
ternationally publicised concerns around the uptake of Pb by internally
displaced populations (IDPs) within Mitrovica since the Kosovan War
(1998–1999) have been highlighted (CDC, 2007; Human Rights
Watch, 2009). Our previouswork has assessed the potential daily intake
of soil-bound PHEs in surface soils and metallurgical waste in the area
using physiologically-based in vitro analyses (Boisa et al., 2013). The
samples analysed in this study (n=33) included 4 smelter waste sam-
ples (from Gornje Polje waste dumps), 24 topsoil samples (1–10 cm
depth from Bosniak Mahalla, Roma Mahalla and Cesmin Lug) and 5
mine tailing samples. The pH of the topsoils was determined using a
Hanna pH209 electrode in a slurry containing sample and deionised
water in a 1:2.5 (w:v) ratio. The pH of the topsoils ranged from slightly
acidic tomoderately alkaline (6.08 to 8.5)with a neutral-mildly alkaline
median of 7.3. Organic matter content was quantiﬁed gravimetrically
by loss-on-ignition (LOI) following the ignition of sample material
at 375 °C for 16 hours (Ball, 1964). The samples indicated a very low–Kosovo (from Boisa et al., 2013).
Fig. 2. Time-dependent extraction of Pb in the simulated epithelial lung ﬂuid (SELF). The
mean (n= 9) with a 1 standard deviation error bar is displayed.
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0.7%. Low organic status soils are typically more friable, especially
when dry, compared to those with higher organic matter status with a
higher aggregate binding potential.
Samples (b250 μm) were dry sieved to obtain the b63 μm size
fraction and fugitive dusts (b10 μm) were extracted from the b63 μm
fraction by wet extraction (e.g. Ljung et al., 2011; Luo et al., 2011)
with the method optimised and adjusted to the laboratory scale in this
study. The low%LOI content of these soils reduced the need for pretreat-
ment with hydrogen peroxide to remove the organic matter. The water
soluble fractions of PHEs can be a source of error for water-based PM10
sampling methods. To assess the loss of Pb during our wet extraction
procedure the supernatant for each sample (the visually clear liquid ob-
tained after centrifugation) was analysed for its Pb content by ICP-MS.
The % loss of Pb during the PM10 extraction (expressed as a % of the
pseudo-total Pb concentration) was consistently low, and ranged from
0.4–0.94%. However, when expressed as a % of the lung bioaccessible
Pb concentration, the loss of Pb during the PM10 extraction ranged
between 1.1 and 7.6% for the majority of the topsoils but the tailing
and smelter samples indicated a far higher % loss of Pb (some samples
in excess of 80%). Given the extremely high Pb concentration in these
wastes, the Pb lost during thewater separation procedure still only rep-
resents b1% of the pseudo-total concentration; so in percentage terms
minimal Pb is extracted from the tailing and smelter samples either at
the water separation stage or by the lung bioaccessibility procedure.
Given the low % loss of Pb from the topsoils we proceeded to extract
PM10 from these samples using the wet extraction technique. All PM10
samples were subsequently subjected, in triplicate, to our developed
IBM.
4. Results and Discussion
4.1. Method development: experimental time
The residence time of inhaled particulate matter in the respiratory
tract is known to vary depending on the characteristics of the material,
the health state of the individual concerned (Caboche et al., 2011), and
the region of the lung being modelled. The lungs act as a continuous
sampler of inhaled particulate matter some of which is deposited in
the lung and of these a proportion is retained (Abraham et al., 1991). In-
deed clearance time of particles can actually be in the order of months
or even years. Typically, PM deposited in the tracheobronchial region
are cleared by two main routes: (1) via mucociliary transport (such
as to the gastrointestinal tract) or (2) to regional lymph nodes or
blood capillaries (Sturm, 2007). Mathematical approaches for modelling
pulmonary clearance are numerous (Stöber and McClellan, 1997), and it
is clear that deposited/deposited in the lung are subject to short-term to
long-term retention processes and require complex multi-compartment
models for simulating tracheobronchial clearance (Sturm, 2007). No con-
sistent experimental extraction time has been applied in the scientiﬁc lit-
erature,with timevariations of between5min and26days reported,with
most studies using≤24 hours (e.g. Caboche et al., 2011). An investigation
to determine a suitable extraction time for the IBM (i.e. optimal or maxi-
mumbioaccessibility)was undertaken using the abundant ball-milled in-
house test soil. The extraction proﬁle indicated that extraction of the bio-
accessible Pb was time dependent, with rapid initial dissolution and a
maximum bioaccessible Pb concentration determined at 96 hours and
then an asymptotic response up to the experimental maximum time of
170 hours (Fig. 2). It has been suggested that about 10–35% of particles
initially deposited in the human bronchial tree are still retained beyond
24 hours (Hoffman and Asgharian, 2003). It has also been suggested
that materials deposited in the alveolar zone (i.e. deep lung) by sedimen-
tation anddiffusion are removed slowly,with a clearance time amounting
to days (Lippman et al, 1980). We concluded that 96 hours (4 days)
provides a suitable approximation of the steady state of inhalation bioac-
cessible Pb. This equates well with other authors (e.g. Wragg and Klinck,2007) who have noted that an extraction time of 100 hours provides a
conservative (maximum) estimate of Pb inhalation bioaccessibility.
4.2. Quality control
Excellent agreement is shown between the measured total Pb
concentrations and their certiﬁcate/guidance values (Table 3). There
are no certiﬁed reference materials for assessing in vitro inhalation bio-
accessibilitymethods. The developed IBMwas thus applied to a range of
certiﬁed reference materials (BCR 038, BCR 143R, BCR 176R, BCR 723),
and a guidancematerial (BGS 102) to investigate the precision and suit-
ability of the approach as assessed using a mass balance approach: the
sum of the stage 1 (inhalation bioaccessible) data and stage 2 (residual
fraction) producing % total recoveries ranging from 100% to 103%
(Table 3). The mass balance results show that the loss (or gain) of Pb
in all the experimental stages were insigniﬁcant indicating that the
analytical protocols employed are robust. For the in vitro inhalation
extraction methodology the precision, expressed as relative standard
deviation (% RSD), is also presented in Table 3. In this study the
in vitro IBM extraction exhibited precision in the range of 5.7 to 16.3%.
The% inhalation bioaccessible fraction (% IBAF) ranged between0.3%
(BCR 038) and 8.4% (BCR 143R) illustrating the low extraction from
a range of environmental matrices with particle sizes ranging from
b10 μm to b105 μm.
4.3. Total and inhalation bioaccessible Pb concentration in PM10 fraction
The range of total and inhalation bioaccessible concentrations in the
smelter, topsoils and tailings fromMitrovica (b10 μm fraction) is shown
in Table 4. The total mean concentration of Pb varied betweenmatrices:
smelter (20,900–72,800 mg kg−1), topsoil (274–13,700 mg kg−1), and
tailings (2990 mg kg−1–25,300 mg kg−1), and also by location (Fig. 3).
The in vitro inhalation bioaccessible fraction (% IBAF) ranged between
0.02 and 11.0%, with high inhalation bioaccessible concentrations
being observed for samples from the Bosniak Mahalla area of Mitrovica
(Fig. 3). Samples without Pb-bearing mineral phases indicated the
highest mean % IBAF (for indicative XRD-derived mineralogy of these
samples the reader is referred to Boisa et al., 2013). The observed
range (0.02 to 11.0% bioaccessibility) closely approximates the range
0.17% to 10.7% previously reported by Harris and Silberman (1988) for
Pb in inhalable particles of ﬂy ash (b22 μm fraction) extracted with ca-
nine serum (a biological ﬂuid selected to mimic the ﬂuid lining human
airways). The mean Pb bioaccessibility obtained for the 5 mine tailings
from Mitrovica (0.29%; % IBAF range: 0.02–1.26) is well below the
values (14.4%, 18.0% and 25.3%) recorded for tailing samples from a
Welsh mine site (Wragg and Klinck, 2007). The large difference ob-
served in inhalation bioaccessibility between these twodifferent studies
may be due to different Pb mineral forms in the samples or differences
Table 3
Determination of lead in certiﬁed reference and guidance materials: total and inhalation bioaccessible fractions.
Certiﬁed reference
or guidance material
Certiﬁed value
(mg kg−1)
Determined concentration
(mg kg−1)
In vitro inhalation bioaccessibility method (IBM) (mg kg−1 Pb)
Stage I (inhalation bioaccessible fraction) Stage II (residual digest) Total content (Stage I + II)
Mean ± SD (n = 3) Mean ± SD (n = 3) % IBAFa % RSDb Mean ± SD (n = 3) Mean (n = 3) % Total recoveryc
BCR 038 262 ± 11 252 ± 3.0 0.8 ± 0.1 0.3 7.50 252 ± 20 253 100
BCR 143R 174 ± 5 172 ± 3.0 14.4 ± 2.2 8.4 15.3 160 ± 2.0 174 101
BCR 176R 5000 ± 500 5024 ± 51 190 ± 31 3.8 16.3 4880 ± 311 5070 101
BCR 723 866 ± 16 851 ± 21 33.8 ± 3.0 4.0 8.90 832 ± 18 866 102
BGS 102 79.4 ± 1.4 70.2 ± 3.4 3.5 ± 0.2 5.0 5.70 68.8 ± 0.6 72.3 103
BCR 038 (ﬂy ash from pulverised coal);
BCR 143R (sewage sludge amended soil);
BCR 176R (ﬂy ash);
BCR 723 (road dust);
BGS 102 (naturally contaminated soil, from North Lincolnshire).
a % IBAF: stage related inhalation bioaccessible fraction, calculated as a fraction of the total concentration.
b % RSD (Relative standard deviation): calculated as (standard deviation / mean)*100.
c % Total recovery: sum of residual and bioaccessible Pb calculated as a fraction of the total concentration.
138 N. Boisa et al. / Environment International 70 (2014) 132–142in chemical composition of the leaching liquids employed in the studies.
The four smelter samples fromKosovo also exhibited a very lowmean %
IBAF (1.20%; range: 0.03–4.60%). Given the variety of composition of
in vitro simulated lung ﬂuids currently in the literature, the fact that
the inhalation bioaccessibility values obtained in this study differ to
ranges previously reported for Pb on similar materials is to be expected.
As previously highlighted, the SELF developed in this study includes an-
tioxidants, large molecular mass proteins (mucin and albumin) and a
surfactant lipid that have the potential to inﬂuence the dissolution ki-
netics of Pb (Cross et al., 2001; Duranti et al., 2001; Gehr et al., 1994;
Thornton et al., 2008). The extent to which this occurs clearly warrants
further investigation; however this was beyond the scope of the current
project.
4.4. The relevance of inhalation bioaccessibility in estimating potential
human health impacts
Human exposure to airborne contaminants can be estimated by
calculation of respiratory intake or inhalable dose. Exposure to Pb in
the resuspendable (PM10) fraction of surface soils and metallurgic
waste was estimated for adult receptors in the study area. Children
are typically considered the most sensitive receptors, being more at
risk following exposure to Pb because their growingbodiesmore readily
absorb the Pb and because their tissues are especially sensitive to
damage (Chandramouli et al., 2009). However, as the developed IBM
is based on information available for adults and as children are not
“mini-adults,” either biologically or physically, we modelled our
inhalable dose for an adult receptor.
In order to consider the relevance of the lung bioaccessibility results
in terms of potential human health impacts we need to calculate a daily
exposure to Pb (daily intake (DI) μg kg−1BW day−1). This was done
using a modiﬁed version of the literature approach detailed in Chen
et al. (2011):
DI ¼ FPbTR PM10  V resp
 
=BW ð3Þ
In Eq. (3), PM10 is the concentration of particles with a diameter less
than 10 μm (μg m−3); FPb is the mass fraction (total or bioaccessible) of
Pb in the PM10; TR is the tracheobronchial retention, expressed as a
fraction (i.e. the fraction of original intake retained in the respiratory
tract once some of the deposited particles have been cleared by the
bodies various clearance mechanisms); Vresp is the inhalation rate
(m3 day−1); and BW is the body weight (kg). The advantage of using
amass fraction for the Pb content and a fraction for the tracheobronchial
retention is that the units generate output from the equation directly as
μg kg−1BW day−1.The parameters used to evaluate the inhalation exposure to Pb in the
Mitrovica samples are summarised in Table 5. Environmental monitor-
ing in the Mitrovica region by Arditsoglou and Samara (2005) reports a
mean (annual) TSP in the local atmosphere of 181 μgm−3. Published ra-
tios of PM10:TSP range from 0.59 to 0.8 in studies where trafﬁc is likely
to be the main source and from 0.37 to 0.53 where mining and industry
are predominant sources (e.g. Berico et al., 1997; Roosli et al., 2000;
Triantafyllou et al., 2006), whilst the U.S. EPA (1995) uses a ratio of 0.5
(PM10:TSP) for windblown dust from aggregate storage areas. In a
recent study measuring PM10 concentrations at locations within
the same study area as ours, a maximum observed concentration of
83 μg m−3 was observed (Shala et al., 2010), consistent with the TSP
value of 181 μg m−3 reported by Arditsoglou and Samara (2005)
when using a PM10:TSP ratio of 0.5. Thismaximumobserved concentra-
tion of 83 μg m−3 PM10 was used to model the inhalation dose.
Another factor that inﬂuences the modelled inhalation dose is the
fraction of particulate matter retained in the respiratory tract following
inhalation. As noted earlier, particles inhaled/deposited in the lung are
subject to short-term to long-term retention processes and require
complex multi-compartment models for simulating tracheobronchial
clearance (Sturm, 2007). To apply a tracheobronchial retention factor
(TR) is clearly an oversimpliﬁcation of the system, but at this stage of
procedural development was considered a pragmatic approach. Chen
et al. (2011) applied 75% for lung retention (based on SFT, 1999) whilst
50% retention is reported after about 5 days according to Sturm (2007).
Again taking a conservative approach, the former retention estimate
used by Chen et al. (2011) is applied in this study.
The estimated inhalation dose (for adults) calculated from the total
Pb concentration in PM10 ranged from 0.005 to 0.242 μg kg−1BW day−1
from the topsoils, 0.053–0.446 μg kg−1BW day−1 from the tailings,
and 0.369–1.284 μg kg−1BW day−1 from the smelter samples. JECFA
(2012) report that an intake of 1.9 μg kg−1BW day−1 is associated
with a population decrease of 3 IQ points, whilst a dietary intake of
0.50 μg kg−1BW day−1, derived using the Integrated Exposure Uptake
Biokinetic (IEUBK) model, has been linked to neurodevelopmental
effects in children (ESFA, 2010). Evidence for the impact of even
low-level environmental Pb exposure on human health, behaviour
and cognition is increasing, along with a growing consensus that there
is likely to be no clear threshold, nor linear dose–response relationship,
between Pb exposures in children and neurodevelopmental impacts
(Bellinger, 2008; Budtz-Jørgensen et al., 2013; Chandramouli et al.,
2009; Grandjean, 2010; Jakubowski, 2011; Lanphear, et al., 2005). A
number of recent studies suggest that the threshold for clinical concern
should be reduced to a blood Pb level of 5 μg dL−1 (e.g. Chandramouli
et al., 2009) whilst the European Food Safety Authority (2010) conclud-
ed that there is no known safe exposure to Pb. Signiﬁcantly, in the USA,
the California Ofﬁce of Environmental Health Hazard Assessment has
Table 4
Descriptive statistics for total and inhalation bioaccessible Pb from theMitrovica samples.
Smelter (n = 4); topsoil (n = 24); tailings (n = 5).
Matrix Mean Minimum Maximum Median
Total concentration (mg kg−1)
Smelter 43,000 20,900 72,800 39,200
Topsoil 3240 274 13,700 2280
Tailings 8450 2990 25,300 4720
Inhalation bioaccessible concentration (mg kg−1)
Smelter 272 7.00 965 58.0
Topsoil 202 9.80 1060 57.4
Tailings 15.0 0.70 49.2 10.2
Inhalation bioaccessible fraction (IBAF) (%)
Smelter 1.20 0.03 4.60 0.08
Topsoil 5.34 0.50 11.00 5.70
Tailings 0.29 0.02 1.26 0.05
Total mass recovery (%)
Smelter 101 99.3 104 100
Topsoil 99.9 96.2 104 99.5
Tailings 101 98.3 102 101
139N. Boisa et al. / Environment International 70 (2014) 132–142developed a 1 μg dL−1 benchmark for source-speciﬁc incremental
change in blood lead levels for protection of school children and
foetuses (OEHHA, 2009). A similar downward revision of the UK guide-
line values for Pb would greatly increase the urban land area with soil
considered as hazardous in terms of its Pb content. The recently re-
leased provisional category 4 screening levels (pC4SL) for Pb base
their upper modelled pC4SLs on a blood Pb concentration of 5 μg dL−1
(DEFRA, 2013). The resultant UK residential (with home grown pro-
duce) pC4SLs for Pb in soil range from 200 to 210 mg kg−1. This is
lower than even theminimumtotal Pb concentration observed in the top-
soils across Mitrovica (Table 4). Our ﬁndings, however, suggest that Pb
within the extracellular lung environment is not readily bioaccessible in
any of the three sample groups (topsoils; smelter waste; tailings).
When daily inhalation doses were calculated using the bioaccessible Pb
concentration the exposure doses are generally lower, by about two or-
ders ofmagnitude, than the doses derived from total Pb. The bioaccessible1200
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Fig. 3. Inhalation bioaccessible Pb concentrations at the different sample locations across Mitro
camps (IDPs) (n= 6); Roma Mahalla (n= 8); Zharkov Potok (Z-P) and Gornje Polje (G-P) (ninhalation dose from topsoil extracted PM10 ranged from 0.0002 to
0.0187 μg kg−1BW day−1, 0.0001–0.0170 μg kg−1BW day−1 from smelter
samples, and 0.0001–0.0009 μg kg−1BW day−1 in the tailing samples. For
the general European population, human exposure to Pb is mainly via
food and water with an average adult Pb dietary exposure ranging from
0.36 to 2.43 μg kg−1BW day−1 in high consumers in Europe (EFSA,
2010). Clearly in contexts such as Mitrovica where non-dietary Pb
exposure from soil and dust may not be negligible and may add to the
exposure burden then the inhalation pathway needs to be considered as
part of the overall risk assessment. This may be particularly relevant as
previous work on oral (ingestion) bioaccessiblity in Northern Kosovo
has indicated the high gastric bioaccessibility of Pb present within these
same topsoils (13.40–92.20%; Boisa et al., 2013). Clearly any inhalation
exposure will add to an already elevated Pb burden to which the local
population are exposed.
A recent study using Pb isotopes to investigate the key sources of Pb
in these topsoils from Mitrovica indicated ratios of 206Pb/207Pb and
208Pb/206Pb that fell between those for smelter waste stored at Gornje
Polje, bedrock from the Mitrovica area and those for Eastern European
petrol combustion residues, with localised inputs from metallurgical
slag resulting from secondary vehicle battery processing. Wind-blown
dispersal of Pb-richwaste from theZvecan smelter (whilst it was active)
and the Gornje Polje tailings dump are the principal sources (FLUVIO,
2010). The social and economic consequences of limited primary
prevention of exposure to Pb have been reported in the literature,
highlighting the beneﬁts of removing sources of lead exposure (Gould
et al., 2009; Grosse et al., 2002; Pichery et al., 2011; Schwartz, 1994).
5. Conclusion
There is growing concern for the impact of PM on human health.
Studies such as ours which seek to develop robust methods to enhance
the reliability and practicality of assessing release from inhaled particles
are needed if we are to adequately assess the potential health risks as-
sociated with exposure to metals in the inhaled fraction. We propose
a new in vitro simulated epithelial lung ﬂuid (SELF) that, in addition to
the full complement of chemical groups present in other formulae,
also contains high molecular mass proteins, antioxidants and aIDP Roma Mahalla Z-P and G-P
vica. Bosniak Mahalla (n=4); Mitrovica City Centre (n=7); internally displaced peoples
= 9). The mean is represented by a circle and the median a solid line through the box.
Table 5
Variables used in calculating the exposure dose of Pb in PM10.
Parameter Description Adult
FPb Total or bioaccessible Pb concentration range in PM10 (dimensionless) Total rangea: 0.0003–0.0728
Bioaccessible rangea: 0.000007 to 0.00106
TR Tracheobronchial retention 0.75b
PM10 Concentration of particles with an aerodynamic diameter less than 10 μm (μg m−3) 83c
Vresp Inhalation rate expressed (m3 day−1) 17d
BW Body weight expressed (kg) 60d
a Reported as mass fraction (mg kg−1 divided by 10−6).
b SFT (1999).
c Shala et al. (2010).
d ESTA (2013).
140 N. Boisa et al. / Environment International 70 (2014) 132–142surfactant. The proposed IBM is designed tomimic the tracheobronchial
tract of the human respiratory system. Given the seemingly contradic-
tory research ﬁndings in the literature on the role of proteins (such as
mucin) and antioxidant reagents with respect to the bioaccessibility of
PHEs, further work is needed in this area. Literature data on the respira-
tory uptake of PHEs are, in general, limited and difﬁcult to compare due
to the lack of a standard procedure to simulate the in vivo respiratory
uptake. Presently there is no human or animal in vivo data to validate
lung bioaccessibility protocols, although the observed range using our
IBM closely approximates the range of 0.17 to 10.7% reported by
Harris and Silberman (1988) for Pb in inhalable particulates of ﬂy ash
(b22 μm fraction) in canine serum. The development of specialised
ﬂuids to mimic other parts of the human respiratory system may
also be required, possibly as a two, or more, phase process such as
the UBM for gastric and intestinal phases (Wragg et al., 2009).
Particles that get into the distal lung are likely to be phagocytosed by
macrophages and then undergo dissolution in the more acidic
phagolysosomal environment within the cell (Stefaniak, 2005). Work
undertaken on roadside dusts (63–125 μm fraction) by Potgieter-
Vermaak et al. (2012) concluded that the Pb concentration released in
their artiﬁcial lysosomal ﬂuid (pH 4.55) was substantially higher than
that found for their Gamble's solution (pH 7.35) and concluded that
this was linked to the reduced extractant pH. A recent study on nano-
particles (b3 μm) of galena (PbS) also indicated high bioaccessibility
in the modelled human lung environment as a result of phagocytosis
(Beeston et al., 2010). The current literature therefore implies that
inhaled particles would have to be phagocytized before signiﬁcant Pb
dissolution occurs (in the more acidic environment). As such, our
developed IBM, based on SELF with a neutral pH (pH 7.4), may be an
underestimate of the overall lung bioaccessibility, and this must be
considered in any estimates of exposure, particularly where the PM10
fraction is dominated by the smaller “respirable” fraction as it is the
smaller particles that are more likely to be phagocytized.
This paper also reports on the application of our IBM method to de-
termine the Pb inhalation bioaccessibility of urban topsoil (and related
samples) from Mitrovica, Kosovo. Although determined inhalation
bioaccessibilities are generally lower, by about two orders ofmagnitude,
than those modelled using total Pb concentration, it is widely accepted
that airborne dust from tailings and other urban and industrial process-
es may represent an important exposure pathway and subsequent risk
to human health. So, whilst the results from our Kosovo study indicate
a low potential inhalation bioaccessibility for Pb (modelled for the neu-
tral pH conditions of the interstitial lung environment), it is not unrea-
sonable to speculate that, under changing climatic conditions (e.g. dry
and arid), or where signiﬁcant prolonged dust or particulate generating
activities are taking place (e.g. unregulated battery reprocessing, demo-
lition and construction sites) or where the inhaled particles are phago-
cytized, inhalation exposure has a signiﬁcant potential to add to an
already elevated Pb burden experienced by the local population. Such
data are important for local policy makers to better enable them to as-
sess risk, especially for those soils/dusts which have elevated levels ofcontamination, providing additional information on potential sources
of Pb exposure.
This paper has focussed solely on the direct inhalation pathway and
consideration of the human health risk via exposure to PHEs requires
assessment of multiple routes (i.e. ingestion, inhalation and dermal
absorption) to allow an overall systemic loading to be derived and
evaluated. Given the signiﬁcance of the inhalation route for certain
PHEs, such as Ni (Environment Agency, 2009b), and in certain contexts
(e.g. dust generating contexts) it is timely that work developing robust
inhalation bioaccessibility protocols receives wider attention by the
bioaccessibility research community. One can only truly deﬁne the
most appropriate in vitro model by comparison with in vivo data. In
the absence of in vivo data our approach was to critically appraise the
literature to contribute to an understanding of the factors pertinent to
the design of simulants of the lung environment and the subsequent ex-
perimental protocol for the study of particle dissolution using a static
dissolution technique. Whilst bioaccessiblity in soils is often highly
site-speciﬁc, the results of this study are also of potential wider value,
allowing for the cross-comparisons between studies focusing on the
same element, method and/or media of interest.
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